Granulomatosis with Polyangiitis
📧 Sign up to get email alerts when something new happens for Granulomatosis with Polyangiitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-10-16FDA Approved: RITUXAN — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Rituxan (rituximab) from Genentech.
-
CLINICAL_TRIALS trial_result · 2008-09-16Clinical Trial Update: Anti-Cytokine Therapy for Vasculitis [Phase 2]
Phase 2 trial update of an anti-cytokine therapy for granulomatosis with polyangiitis and related vasculitides; the study has completed.
-
CLINICAL_TRIALS research · 2008-09-12Clinical Trial Update: Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides [Phase 2]
Phase 2 trial comparing cyclophosphamide versus methotrexate for remission maintenance in systemic necrotizing vasculitides. The current tri…
-
EMA withdrawal · 2008-06-19EMA Application withdrawn: Spanidin (gusperimus trihydrochloride) — Euro Nippon Kayaku GmbH
EU application for Spanidin (gusperimus trihydrochloride) withdrawn; previously targeted Wegener Granulomatosis (granulomatosis with polyang…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Steroids and Methotrexate to Treat Systemic Vasculitis [Phase 2]
Phase 2 trial evaluating steroids plus methotrexate for systemic vasculitis completed; results update provided.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes [Phase 2]
A Phase 2 trial comparing treatments to maintain remission in granulomatosis with polyangiitis (Wegener's granulomatosis) and related vascul…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Etanercept to Treat Wegener's Granulomatosis [Phase 2]
Phase 2 clinical trial update for etanercept in granulomatosis with polyangiitis (Wegener's granulomatosis) has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies [Phase 1]
This open-label Phase 1 pilot study assessed the safety and potential efficacy of rituximab in patients with granulomatosis with polyangiiti…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis [Phase 1]
Phase I study of recombinant human interleukin-10 (SCH 52000) in patients with granulomatosis with polyangiitis (Wegener's granulomatosis) h…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Diagnostic Effectiveness of Virtual Bronchoscopy [Phase 1]
Phase 1 clinical trial update evaluating the diagnostic effectiveness of virtual bronchoscopy for lung-related diseases.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides
Clinical trial evaluating a cyclophosphamide and prednisone regimen followed by methotrexate for vasculitis, including granulomatosis with p…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Treatment of Wegener's Granulomatosis With Cyclophosphamide [Phase 2]
Phase 2 trial examining cyclophosphamide for vasculitis due to granulomatosis with polyangiitis (Wegener's granulomatosis) has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Daclizumab to Treat Wegener's Granulomatosis [Phase 2]
Phase 2 clinical trial of daclizumab for granulomatosis with polyangiitis has completed; the update notes trial status and sponsor but does …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions [Phase 1]
A Phase 1 study of mycophenolate mofetil for granulomatosis with polyangiitis (Wegener's granulomatosis) and related vasculitic conditions h…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis
Completed clinical trial analyzing bronchial tissue and fluid from patients with Granulomatosis with polyangiitis to study disease biology.
-
CLINICAL_TRIALS trial_result · 2007-12-28Clinical Trial Update: Etanercept for Wegener's Granulomatosis [Phase 2, Phase 3]
Phase 2 and Phase 3 trials evaluating etanercept for granulomatosis with polyangiitis (Wegener's granulomatosis) have been completed.
-
CLINICAL_TRIALS trial_result · 2007-11-19Clinical Trial Update: RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides [NA]
This completed trial compared infliximab versus rituximab in systemic necrotizing vasculitides, including granulomatosis with polyangiitis, …
-
CLINICAL_TRIALS trial_result · 2007-10-10Clinical Trial Update: WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides [Phase 3]
Phase 3 trial update for WEGENT comparing methotrexate versus azathioprine as maintenance therapy in ANCA-associated vasculitis, including g…
-
CLINICAL_TRIALS trial_result · 2007-02-01Clinical Trial Update: Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides [Phase 2, Phase 3]
A completed Phase 2/3 trial comparing pulse-dose versus continuous cyclophosphamide for induction of remission in ANCA-associated vasculitis…
-
CLINICAL_TRIALS trial_result · 2006-11-29Clinical Trial Update: Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol. [Phase 3]
Phase 3 trial comparing alendronate to alfacalcidol for the prevention of glucocorticoid-induced osteoporosis in rheumatic disease patients …